Sequoia Financial Advisors, LLC Lineage Cell Therapeutics, Inc. Transaction History

Sequoia Financial Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 23, 2020	SELL	$0.75 - $1.09 $32,180 - $46,768	-42,907 Closed	0 $0
Q2 2020 Aug 25, 2020	BUY	$0.71 - $1.18 $30,463 - $50,630	42,907 New	42,907 $37,000
Q2 2020 Aug 11, 2020	SELL	$0.71 - $1.18 $48,791 - $81,090	-68,721 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$0.54 - $1.01 $37,109 - $69,408	68,721 New	68,721 $61,000

134

106M

22.1K

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $115M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

Get notified when there are updates to the investment portfolio of Sequoia Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sequoia Financial Advisors, LLC with notifications on news.